A federal judge dismissed a lawsuit that sought to block a California law requiring drug makers to not only provide advance notice of price hikes, but also give the reasons for any increases.
In explaining his decision, U.S. District Judge Morrison England Jr. ruled that the Pharmaceutical Research and Manufacturers of America failed to show that the court has jurisdiction to hear the case. However, he wrote that the trade group can refile its case if it can prove that any potential harm to drug makers falls “outside the realm of conjecture,” a step that would give PhRMA standing to press it case.
About the Author Reprints
Very Good